AnPac Bio-Medical Science
Ambler
About AnPac Bio-Medical Science
Anpac Bio-Medical Science is a biotechnology company that focuses on early cancer screening and detection. A variety of cancer screening and detection tests are carried out by AnPac Bio, including tests for biochemistry, immunology, genomics, and CDA (Cancer Differentiation Analysis). AnPaC Bio seeks to unite experts from various fields in order to create, disseminate, and implement accessible early disease detection tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $44.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2023)
- Ticker: nasdaq:ANPC
- Website: anpacbio.com
- Phone: (314)326-7292
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/anpac-bio-medical-science-182803 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.